Saturn V Capital Management LP Diversified Active

Location: Austin, TX

CIK: 0001964437 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value: $261M (100.0% shares, 0.0% debt)

Holdings (23)

CYTK CYTOKINETICS INC 14.3%

Value $37.42M Shares 448,144 Est. Cost $39.36 Unrealized -8.0%

CRNX CRINETICS PHARMACEUTICALS IN 10.7%

Value $28.01M Shares 787,132 Est. Cost $18.62 Unrealized +64.7%

KALV KALVISTA PHARMACEUTICALS INC 8.5%

Value $22.14M Shares 1,807,563 Est. Cost $7.51 Unrealized +21.1%

ARGX ARGENX SE 7.5%

Value $19.47M Shares 51,175 Est. Cost $394.19 Unrealized —

— CYMABAY THERAPEUTICS INC 6.8%

Value $17.72M Shares 750,250 Est. Cost $3.60 Unrealized —

ASND ASCENDIS PHARMA A/S 6.4%

Value $16.6M Shares 131,759 Est. Cost $110.99 Unrealized —

AMLX AMYLYX PHARMACEUTICALS INC 6.2%

Value $16.18M Shares 1,099,268 Est. Cost $20.02 Unrealized -23.4%

ANAB ANAPTYSBIO INC 5.4%

Value $14.23M Shares 664,276 Est. Cost $18.84 Unrealized -8.5%

BMRN BIOMARIN PHARMACEUTICAL INC 4.4%

Value $11.49M Shares 119,188 Est. Cost $92.92 Unrealized -4.8%

SNDX SYNDAX PHARMACEUTICALS INC 4.3%

Value $11.21M Shares 518,799 Est. Cost $19.32 Unrealized -20.5%

— MERUS N V 4.1%

Value $10.71M Shares 389,333 Est. Cost $27.10 Unrealized —

— ITEOS THERAPEUTICS INC 3.5%

Value $9.069M Shares 828,232 Est. Cost $14.98 Unrealized —

APLS APELLIS PHARMACEUTICALS INC 3.3%

Value $8.556M Shares 142,927 Est. Cost $50.73 Unrealized 0.0%

BIIB BIOGEN INC 3.2%

Value $8.402M Shares 32,469 Est. Cost $275.18 Unrealized -10.7%

— ASTRIA THERAPEUTICS INC 2.9%

Value $7.608M Shares 990,663 Est. Cost $7.99 Unrealized —

— MORPHIC HLDG INC 2.3%

Value $6.132M Shares 212,343 Est. Cost $27.88 Unrealized —

COGT COGENT BIOSCIENCES INC 1.7%

Value $4.449M Shares 756,681 Est. Cost $11.61 Unrealized -34.0%

IRON DISC MEDICINE INC 1.4%

Value $3.742M Shares 64,784 Est. Cost $51.20 Unrealized 0.0%

FOLD AMICUS THERAPEUTICS INC 1.1%

Value $2.838M Shares 199,973 Est. Cost $11.35 Unrealized 0.0%

ALNY ALNYLAM PHARMACEUTICALS INC 0.8%

Value $1.977M Shares 10,327 Est. Cost $170.34 Unrealized 0.0%

PHAT PHATHOM PHARMACEUTICALS INC 0.6%

Value $1.461M Shares 160,075 Est. Cost $8.62 Unrealized 0.0%

— JASPER THERAPEUTICS INC 0.4%

Value $1.094M Shares 1,386,215 Est. Cost $0.70 Unrealized —

— AMBRX BIOPHARMA INC 0.3%

Value $752K Shares 52,781 Est. Cost $14.24 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CYTK	CYTOKINETICS INC	448,144	$37.42M	14.3%	$39.36	-8.0%	COM NEW	23282W605
CRNX	CRINETICS PHARMACEUTICALS IN	787,132	$28.01M	10.7%	$18.62	+64.7%	COM	22663K107
KALV	KALVISTA PHARMACEUTICALS INC	1,807,563	$22.14M	8.5%	$7.51	+21.1%	COM	483497103
ARGX	ARGENX SE	51,175	$19.47M	7.5%	$394.19	—	SPONSORED ADR	04016X101
—	CYMABAY THERAPEUTICS INC	750,250	$17.72M	6.8%	$3.60	—	COM	23257D103
ASND	ASCENDIS PHARMA A/S	131,759	$16.6M	6.4%	$110.99	—	SPONSORED ADR	04351P101
AMLX	AMYLYX PHARMACEUTICALS INC	1,099,268	$16.18M	6.2%	$20.02	-23.4%	COM	03237H101
ANAB	ANAPTYSBIO INC	664,276	$14.23M	5.4%	$18.84	-8.5%	COM	032724106
BMRN	BIOMARIN PHARMACEUTICAL INC	119,188	$11.49M	4.4%	$92.92	-4.8%	COM	09061G101
SNDX	SYNDAX PHARMACEUTICALS INC	518,799	$11.21M	4.3%	$19.32	-20.5%	COM	87164F105
—	MERUS N V	389,333	$10.71M	4.1%	$27.10	—	COM	N5749R100
—	ITEOS THERAPEUTICS INC	828,232	$9.069M	3.5%	$14.98	—	COM	46565G104
APLS	APELLIS PHARMACEUTICALS INC	142,927	$8.556M	3.3%	$50.73	0.0%	COM	03753U106
BIIB	BIOGEN INC	32,469	$8.402M	3.2%	$275.18	-10.7%	COM	09062X103
—	ASTRIA THERAPEUTICS INC	990,663	$7.608M	2.9%	$7.99	—	COM	04635X102
—	MORPHIC HLDG INC	212,343	$6.132M	2.3%	$27.88	—	COM	61775R105
COGT	COGENT BIOSCIENCES INC	756,681	$4.449M	1.7%	$11.61	-34.0%	COM	19240Q201
IRON	DISC MEDICINE INC	64,784	$3.742M	1.4%	$51.20	0.0%	COM	254604101
FOLD	AMICUS THERAPEUTICS INC	199,973	$2.838M	1.1%	$11.35	0.0%	COM	03152W109
ALNY	ALNYLAM PHARMACEUTICALS INC	10,327	$1.977M	0.8%	$170.34	0.0%	COM	02043Q107
PHAT	PHATHOM PHARMACEUTICALS INC	160,075	$1.461M	0.6%	$8.62	0.0%	COM	71722W107
—	JASPER THERAPEUTICS INC	1,386,215	$1.094M	0.4%	$0.70	—	COM	471871103
—	AMBRX BIOPHARMA INC	52,781	$752K	0.3%	$14.24	—	COM	641871108